These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 30402748

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Human genetics in atypical hemolytic uremic syndrome-its role in diagnosis and treatment].
    Knoop M, Haller H, Menne J.
    Internist (Berl); 2018 Aug; 59(8):799-804. PubMed ID: 29995248
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report.
    Sengul Samanci N, Ayer M, Ergen A, Ozturk S.
    Transfus Apher Sci; 2015 Jun; 52(3):314-6. PubMed ID: 25634788
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Liver transplantation for aHUS: still needed in the eculizumab era?
    Coppo R, Bonaudo R, Peruzzi RL, Amore A, Brunati A, Romagnoli R, Salizzoni M, Galbusera M, Gotti E, Daina E, Noris M, Remuzzi G.
    Pediatr Nephrol; 2016 May; 31(5):759-68. PubMed ID: 26604087
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Efficacy and safety of the long-acting C5 inhibitor ravulizumab in patients with atypical hemolytic uremic syndrome triggered by pregnancy: a subgroup analysis.
    Gäckler A, Schönermarck U, Dobronravov V, La Manna G, Denker A, Liu P, Vinogradova M, Yoon SS, Praga M.
    BMC Nephrol; 2021 Jan 06; 22(1):5. PubMed ID: 33407224
    [Abstract] [Full Text] [Related]

  • 53. Systemic lupus erythematosus presenting with atypical hemolytic uremic syndrome: a case report and review of the literature.
    Smith J, Hans V, Yacyshyn E, Rouhi A, Oliver M.
    Rheumatol Int; 2024 Oct 06; 44(10):2213-2225. PubMed ID: 38502235
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Case Report: Variable Pharmacokinetic Profile of Eculizumab in an aHUS Patient.
    Bouwmeester RN, Ter Avest M, Wijnsma KL, Duineveld C, Ter Heine R, Volokhina EB, Van Den Heuvel LPWJ, Wetzels JFM, van de Kar NCAJ.
    Front Immunol; 2020 Oct 06; 11():612706. PubMed ID: 33519821
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Prophylactic eculizumab for kidney transplantation in a child with atypical hemolytic uremic syndrome due to complement factor H mutation.
    Ranch D, Crowther B, Arar M, Assanasen C.
    Pediatr Transplant; 2014 Sep 06; 18(6):E185-9. PubMed ID: 24931815
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.